Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.61 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.41 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.40 |
| ▸ | MMP8 | P22894 | 2/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.40 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9135588 | 0.84 | LMNA (0.57) | LMNACYP2D6TRPA1TAAR1SLC6A2 | |
| SCHEMBL10087170 | 0.80 | CASR (0.44) | LMNACYP2D6TRPA1TAAR1ADRB2 | |
| SCHEMBL29766278 | 0.80 | LMNA (0.57) | LMNACYP2D6TRPA1TAAR1SLC6A2 | |
| SCHEMBL9135600 | 0.80 | TRPA1 (0.50) | LMNACYP2D6TRPA1TAAR1SLC6A2 | |
| SCHEMBL29587381 | 0.80 | CYP2D6 (0.47) | LMNACYP2D6CYP3A4SIGMAR1CASR | |
| SCHEMBL16589312 | 0.78 | CASR (0.53) | CASR | |
| SCHEMBL13996918 | 0.77 | CASR (0.57) | ALDH1A1ADRB2CASR | |
| SCHEMBL14161468 | 0.77 | LMNA (0.63) | LMNACYP2D6TRPA1TAAR1SLC6A2 | |
| SCHEMBL11818840 | 0.77 | LMNA (0.63) | LMNACYP2D6TRPA1TAAR1SLC6A2 | |
| SCHEMBL23901642 | 0.76 | ENPEP (0.48) | LMNACYP2D6TRPA1TAAR1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106796401-A | Pattern forming method, composition for forming upper layer film, resist pattern, and method for manufacturing electronic device | 富士胶片株式会社 | 2017-05-31 | — | — | CN | disclosed |
| CN-106716257-A | Pattern forming method, resist pattern, and electronic device manufacturing method | 富士胶片株式会社 | 2017-05-24 | — | — | CN | disclosed |
| CN-106605174-A | Pattern forming method, composition for forming protective film, method for manufacturing electronic component, and electronic component | 富士胶片株式会社 | 2017-04-26 | — | — | CN | disclosed |
| CN-103619947-A | Active energy ray-curable coating resin composition | KANEKA CORP | 2014-03-05 | — | — | CN | disclosed |
| US-8124634-B2 | CB1 receptor modulators | 7TM PHARMA A/S (DK) | 2012-02-28 | — | — | US | disclosed |
| US-7888363-B2 | 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-amino/thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-02-15 | — | — | US | disclosed |
| US-20100010061-A1 | CB1 RECEPTOR MODULATORS | 7TM PHARMA A/S (DK) | 2010-01-14 | — | — | US | disclosed |
| US-20070142380-A1 | Viral Polymerase Inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-06-21 | — | — | US | disclosed |
| US-7223785-B2 | Viral polymerase inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070142380-A1 | Viral Polymerase Inhibitors | POLM, POLR2H, POLR2A | LMNA 2179/4885CYP2D6 865/4885TRPA1 2999/4885 |
| US-20100010061-A1 | CB1 RECEPTOR MODULATORS | CNR1, CNR2, GPR6 | LMNA 4443/4885CYP2D6 893/4885TRPA1 356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.